[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ilzizzo Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1690388245.png) Investor Gadget 🕵️‍♂️🧬📈 [@ilzizzo](/creator/twitter/ilzizzo) on x 1742 followers
Created: 2025-07-28 16:45:14 UTC

$SRPT @US_FDA Sarepta Therapeutics announced ELEVIDYS was not linked to a recent patient death in Brazil.

Does this mean the stock moves back to the $18-$20 level? 

The FDA looks really bad here. Requesting Serepta to pull ELEVIDY without a thorough investigation. You’d think that when the FDA decides something it wouldn’t be based on assumption, right? Time to dismantle the FDA and those that put them in their roles.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1949873795940151328/c:line.svg)

**Related Topics**
[brazil](/topic/brazil)
[sarepta therapeutics](/topic/sarepta-therapeutics)
[$srpt](/topic/$srpt)
[investment](/topic/investment)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/ilzizzo/status/1949873795940151328)